Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
The Lancet Diabetes and Endocrinology(3)
European Journal of Endocrinology(2)
Expert Review of Endocrinology and Metabolism(1)
Área temáticas
Farmacología y terapéutica(3)
Medicina y salud(1)
Problemas sociales y servicios a grupos(1)
Salud y seguridad personal(1)
Origen
scopus(6)
Consensus on diagnosis and management of Cushing's disease: a guideline update
ReviewAbstract: Cushing's disease requires accurate diagnosis, careful treatment selection, and long-term managementPalabras claves:Autores:Bancos I., Ben-Shlomo A., Bertherat J., Biermasz N.R., Biller B.M.K., Boguszewski C.L., Bronstein M.D., Buchfelder M., Carmichael J.D., Casanueva F.F., Castinetti F., Chanson P., Findling J.W., Fleseriu M., Gadelha M., Geer E.B., Giustina A., Grossman A., Gurnell M., Ho K., Ioachimescu A.G., Kaiser U.B., Karavitaki N., Katznelson L., Kelly D.F., Lacroix A., McCormack A.I., Melmed S., Molitch M., Mortini P., Newell-Price J., Nieman L.K., Pereira A.M., Petersenn S., Pivonello R., Raff H., Reincke M., Richard J. Auchus, Salvatori R., Scaroni C., Shimon I., Stratakis C.A., Swearingen B., Tabarin A., Takahashi Y., Theodoropoulou M., Tsagarakis S., Valassi E., Varlamov E.V., Vila G., Wass J., Webb S.M., Zatelli M.C.Fuentes:scopusEfficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial
ArticleAbstract: Background: Levoketoconazole is a ketoconazole stereoisomer in development for treatment of Cushing'Palabras claves:Autores:Biller B.M.K., Cohen F., Elenkova A., Feelders R.A., Fleseriu M., Geer E.B., Greenman Y., Pivonello R., Richard J. Auchus, Salvatori R., Witek P.Fuentes:scopusEfficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
ArticleAbstract: Background: Cushing's disease is a rare endocrine disorder characterised by cortisol overproductionPalabras claves:Autores:Bertagna X., Biller B.M.K., Findling J.W., Fleseriu M., Gu F., Kim J.H., Lacroix A., Laplanche A., Lee E.J., Leelawattana R., Newell-Price J., O'Connell P., Pedroncelli A.M., Pivonello R., Richard J. Auchus, Shimatsu A., Tauchmanova L.Fuentes:scopusLevoketoconazole treatment in endogenous Cushing’s syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes
ArticleAbstract: Objective: This extended evaluation (EE) of the SONICS study assessed the effects of levoketoconazolPalabras claves:Autores:Biller B.M.K., Buchfelder M., Cohen F., Feldt-Rasmussen U., Fleseriu M., Geer E.B., Greenman Y., Heaney A.P., Kennedy L., Pivonello R., Richard J. Auchus, Salvatori R., Zacharieva S.Fuentes:scopusLevoketoconazole: a novel treatment for endogenous Cushing's syndrome
ArticleAbstract: Introduction: Endogenous Cushing’s syndrome (CS) is a rare, life-threatening endocrine disorder thatPalabras claves:cortisol, Cushing’s disease, Cushing’s syndrome, Ketoconazole, levoketoconazole, medical therapy, steroidogenesis inhibitorAutores:Biller B.M.K., Fleseriu M., Pivonello R., Richard J. Auchus, Salvatori R., Zacharieva S.Fuentes:scopusLong-term outcomes of osilodrostat in Cushing’s disease: LINC 3 study extension
ArticleAbstract: Objective: To investigate the long-term efficacy and tolerability of osilodrostat, a potent oral 11βPalabras claves:Autores:Belaya Z., Biller B.M.K., Feelders R.A., Fleseriu M., Houde G., Izquierdo M., Newell-Price J., Pedroncelli A.M., Pivonello R., Richard J. Auchus, Roughton M., Scaroni C., Shimatsu A., Vila G., Walia R.Fuentes:scopus